Sign Up Now For
HEALTHbeat
Our FREE E-mail Newsletter

In each issue of HEALTHbeat:

  • Get trusted advice from the doctors at Harvard Medical School
  • Learn tips for living a healthy lifestyle
  • Stay up-to-date on the latest developments in health
  • Receive special offers on health books and reports
  • Plus, receive your FREE Bonus Report, Living to 100: What's the secret?

[ Maybe Later ] [ No Thanks ]

Check out these newly released Special Health Reports from Harvard Medical School
Learn How

New Releases

You can't buy good health but you can buy good health information. Check out these newly released Special Health Reports from Harvard Medical School:

New weight-loss drugs provide more options for overweight women, from Harvard Women's Health Watch

The first new weight-loss drugs in more than a decade are now on pharmacists' shelves. Will these medications provide the solution many overweight women are seeking? The September 2012 issue of Harvard Women's Health Watch looks at the benefits—and risks—of both new and established weight-loss drugs.

In June, the FDA approved lorcaserin (Belviq). It suppresses hunger by stimulating a receptor serotonin, a chemical messenger in the brain that regulates fullness and metabolism. A month later, the FDA approved Qsymia, a combination of phentermine and the antiseizure/antimigraine drug topiramate. Qsymia also suppresses appetite, and it appears to be more effective for weight loss than any other single drug.

These highly anticipated new medications join several existing weight-loss drugs. Orlistat (Xenical) works by blocking fat absorption, while phentermine (Adipex-P, Pro-Fast), diethylpropion (Tenuate), and phendimetrazine (Bontril, Adipost, Anorex-SR) suppress appetite.

These drugs can promote weight loss, but they can't "cure" obesity. "The biggest message that I try to relate to patients is that there is no magic bullet," says Dr. W. Scott Butsch, an obesity specialist who is an instructor in medicine at Harvard Medical School. In studies of weight-loss medications, women lost about 5% to 10% of their initial body weight over a year. But they also had to watch their diet and exercise.

How do you know if you're a good candidate for weight-loss drugs? You might be if

  • you have a BMI higher than 30 (the definition of obesity), or have a BMI higher than 27 along with health problems related to your weight—such as type 2 diabetes (you can calculate your BMI at www.health.harvard.edu/bmi).
  • you are overweight and actively dieting and exercising, but are unable to lose weight.

You'll need to consider with your doctor whether the risks of using a weight-loss drug, which range from heart problems and liver damage to possible addiction, are worth the weight you'll lose on it. For some overweight and obese women, they may be. Losing just 5% to 10% of body weight can help reduce disease risk factors such as high blood pressure, blood sugar, and cholesterol.

Read the full-length article: "Weight-loss drug review"

Also in this issue of the Harvard Women's Health Watch

  • What's the beef with meat?
  • Ask the doctor: Should I buy a blood pressure monitor?
  • Ask the doctor: How can I deal with jet lag?
  • Vitamin D and calcium supplements: Take them or leave them?
  • Surviving cancer-what happens next?
  • Weight-loss drug review
  • Making smart screening decisions: Colon cancer screening
  • In the journals: Unique stroke risks in women with atrial fibrillation
  • In the journals: Still smoking? Study finds quitting has benefits at any age
  • In the journals: Staying fit might lower your odds of getting breast cancer
  • In the journals: An apple a day-plus a walk-might contribute to a longer life

More Harvard Health News »


About Harvard Health Publications

Harvard Health Publications publishes four monthly newsletters--Harvard Health Letter, Harvard Women's Health Watch, Harvard Men's Health Watch, and Harvard Heart Letter--as well as more than 50 special health reports and books drawing on the expertise of the 8,000 faculty physicians at Harvard Medical School and its world-famous affiliated hospitals.